Call for Abstract
7th International Conference on Bacteriology and Infectious Diseases, will be organized around the theme “Exploring Innovative Research in Bacteriology and Infectious Diseases”
Bacteriology Congress 2018 is comprised of 14 tracks and 113 sessions designed to offer comprehensive sessions that address current issues in Bacteriology Congress 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Bacteria are microscopic, single-cell organisms that live almost everywhere. Bacteria live in every climate and location on earth. Some are airborne while others live in water or soil. Bacteria live on and inside plants, animals, and people. Bacterial ecology is defined as the interaction between bacteria and with their environment. Bacteria play a vital role in the biosphere and certain key processes, such as, the production and oxidation of methane, soil formation, conversion of rock to soil etc. Major researches in bacteriology over the past years resulted in the development of many useful vaccines. Bacterial cells are about 2 µm (micrometers) long and 0.5 µm in diameter. Bacteria exist in different shapes like rod-shaped (bacilli), spherical (cocci), or helical (spirilla). Bacteria are lack membrane bound organelles, contains single loop DNA, it generally undergo conjugation. There are techniques like staining to differentiate Gram positive and Gram negative bacteria. Compared to virus, cost for antibiotics is low still 700 million infections were found every year.
- Track 1-1Bacteriophage ecology, history, and behavior
- Track 1-2Microbe-Host Interactions as virulence determinants
- Track 1-3Target Drug Interactions, Medication and Validation
- Track 1-4Bacterial cell morphology & bacterial manipulation of host physiology and innate immune responses
- Track 1-5Nutrition: Growth and control of bacteria
- Track 1-6Bacterial genomics and regulation
- Track 1-7Bacterial signal transduction networks
- Track 1-8Bacterial secretion and effectors systems
- Track 1-9Molecular mechanisms of bacterial pathogenesis
Accurate and definitive bacterial identification is essential for correct disease diagnosis, treatment of infection and trace-back of disease outbreaks associated with microbial infections. Bacterial identification is used in a wide variety of applications including microbial forensics, criminal investigations, bio-terrorism threats and environmental studies. Traditional methods of bacterial identification rely on phenotypic identification of the causative organism using gram staining, culture and biochemical methods. For identification of bacteria tests can be done like citrate utilization test, methyl red test, indole production test. In the past decade or so, molecular techniques have proven beneficial in overcoming some limitations of traditional phenotypic procedures for the detection and characterization of bacterial phenotypes. Several non-culture based methods have emerged in the past 15 years. Real time PCR and microarrays are currently the most commonly employed molecular techniques.
- Track 2-1Mass spectrometry techniques
- Track 2-2By Metabolism
- Track 2-3Citrate utilization test
- Track 2-4Sugar fermentation test
- Track 2-5By differential staining
- Track 2-6Methyl Red test
- Track 2-7Indole production test
- Track 2-8Bioanalytical sensors and Biodetection
- Track 2-9Antigen and antibody detection tests
Clinical bacteriology supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. These are the types of specimens used in clinical pathology. They are blood, urine, sputum, and other body fluids, in which it deals with health care, especially the diagnosis and treatment of disorders affecting the female reproductive system.The market is divided on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World. Asia-Pacific and some countries in Rest of the World owing to rapidly growing prevalence and awareness about the diseases caused due to gram-positive bacteria and its chronic effects. Bacterial clinical studies include clinical microbiologyn and bacterial genome sequencing.The value of microbial and microbial physiology market is projected to increase to $4,456.37 million by 2019 at a CAGR of 15.3% from 2014.
- Track 3-1Bacteria in blood for transfusion
- Track 3-2Treatment of bacterial conjunctivitis
- Track 3-3Clinical microbiology with bacterial genome sequencing
- Track 3-4Clinical implications and microbiology of bacterial persistence
- Track 3-5Clinical microbiology of bacterial and fungal sepsis
Phyto bacteriology is a branch of bacteriology that deals with organisms associated with pathogenic for plants. This bacteria causes a small proportion of plant diseases, this does not mean that these diseases are unimportant. Other biotic agents implicated in plant diseases are fungi, viruses and nematodes, abiotic factors may also produce diseases like symptoms. Pathogenic tests can be done for the prevention of disease. There are 1,700 fortune organizations globally with more than 1200 premium studies in a year with a good market research firm worldwide annually.
- Track 4-1Epidemiology of bacterial diseases
- Track 4-2Characterization, identification
- Track 4-3Pathogenicity tests
- Track 4-4Beneficial plant-bacterial interactions
- Track 4-5Re-isolation
- Track 4-6Gram-positive and fastidious phytopathogenic bacteria
- Track 4-7Gamma Proteobacterial phytopathogens and beneficials
- Track 4-8Alpha and beta Proteobacterial phytopathogens and beneficials
- Track 4-9Virulence and host defense
- Track 5-1Clinical Immunology
- Track 5-2Immune Response
- Track 5-3Cancer Immunotherapy
- Track 5-4Immune System Disorders
- Track 5-5Acquired Immunity
- Track 5-6Neuro immunology
- Track 5-7Immuno Pathology
- Track 5-8Anti Therapy and Immune System
- Track 5-9Immunotoxicology
- Track 5-10Vaccines and Immune Therapy
Bacterial pathogenesis is the process by which bacteria infects a host. Not all bacteria are pathogens but some of them have the ability for pathogenesis. Many bacterial Infection forms biofilms with which its pathogenic nature increases. Certain pathogens like Pseudomonas syringe injects virulence in plant host causing diseases. For the Diagnosis of Pathogenic microorganisms Direct Examination and Techniques includes Immunofluorescence, immuno-peroxidase staining, and other immunoassays may detect specific microbial antigens. Genetic probes identify genus- or species-specific DNA or RNA sequences. Forensic evidence involves application of forensic science, technology or "forensics", in order to identify the scene of an accident, specific objects from the trace evidence and often at a crime scene. It is usually submitted to court, which are obtained by scientific methods like by blood test, DNA test.
- Track 6-1Models for Studying Bacterial Pathogenesis
- Track 6-2Strategies for Identifying Bacterial Pathogenicity Genes
- Track 6-3Genetic Determinants of Bacterial Pathogenicity
- Track 6-4Mechanisms of bacterial pathogenicity
- Track 6-5Pathogenic susceptibility
- Track 6-6Host-mediated Pathogenesis
- Track 6-7Immune responses
Infectious Diseases and microbiology is in various aspects of infectious diseases and host pathogen interactions, including the pathogenesis of microbial infectious at the cellular and molecular levels as they relate to developing methods for disease prevention. There are many branches in bacteriology that are related to public health like food bacteriology, myco bacteriology. The market include Danaher Corporations (U.S), Becton Dickinson and company (U.S), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc.(U.S), Bruker Corporations (U.S), Hologic, Inc. (U.S), among others.
- Track 7-1Enteric Bacteriology
- Track 7-2Food Bacteriology
- Track 7-3Myco Bacteriology
- Track 7-4Water bacteriology
- Track 7-5Practical Bacteriology
- Track 7-6Parasitology
- Track 7-7Haematology
During the past 10 years, genomics and bacterial genomics based approaches have a profound impact on the field of microbiology. Because of their larger genome sizes, genome sequencing efforts on fungi and unicellular eukaryotes were slower to get started than projects focused on prokaryotes; however, today there are a number of genome sequences available from both of these groups of organisms that have led to significant improvements in overall sequence annotation and also shed considerable light on novel aspects of their biology. Microarrays are currently the most commonly employed molecular techniques.
According to the World Health Organization more than 1 million people acquire a sexually transmitted infection (STI) every day and an estimated 500 million people become ill with Chlamydia, gonorrhoea, syphilis or trichomoniasis every year.
- Track 8-1Genetic and Evolutionary Computing
- Track 8-2Genome Mapping and Genomics in Microbes
- Track 8-3Next Generation DNA Led Technologies
- Track 8-4QSAR and Molecular Modeling
- Track 8-5D PAGE Map Analysis
- Track 8-6Analysis of Large and Complex Data
- Track 8-7Recent Advances in Natural Computing
- Track 8-8Systems Biology and Bioinformatics
Pathogenic bacteria are inflamative bacteria which are capable of causing disease when enters into the body which can spread through water, air, soil and also through physical contact. Mostly bacteria’s are harmless and beneficial but some are pathogenic. The global medical and clinical microbiology market is valued at $6,727.29 million in 2014 and is expected to grow at a CAGR of 13.03% between 2014 and 2019. Increasing disease burden of infectious diseases and increased funding for healthcare expenditure are the important growth drivers for this market during the forecast period.
- Track 9-1Bacterial STDs
- Track 9-2Bacterial metabolism and normal flora
- Track 9-3Medical mycology & Medical parasitology
- Track 9-4Antimicrobial treatment from Bench-top to Clinic, gene silencing and chemotherapy
- Track 9-5Genomics, clinical microbiology and virology
- Track 9-6Microbial strains & antibiotic applications
- Track 9-7Bacterial types and complexity
- Track 9-8Bacteria and Probiotics
- Track 9-9Immunology
Infectious diseases are caused by microscopic organisms such as bacteria, virus, fungi or parasites from one person to another. They can be spread by any media where there is a germ. Germs can be spread by direct or indirect contact. Vaccination and maintenance of proper hygiene and medicines help in the prevention of infection.
- Track 10-1Gastroenteritis and neonatal meningitis
- Track 10-2Cardiovascular Diseases
- Track 10-3Nervous and Mental Diseases
- Track 10-4Diseases in Dermatology
- Track 10-5Neurological Diseases
- Track 10-6Endocrine Diseases
- Track 10-7Urinary Tract infections
- Track 10-8Sexually transmitted diseases
- Track 10-9Salmonellosis and shigellosis
- Track 10-10Respiratory Diseases
Bacterial infections are treated by administering antibiotics to the patients. Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests. Sub types of diagnoses include clinical, laboratory, radiology. Advanced methods have been implemented to diagnose the infection in any part of the body.
- Track 11-1Antibiotics
- Track 11-2Traditional medicines
- Track 11-3Herbal treatment
- Track 11-4Antibacterials
- Track 11-5Antimicrobials
- Track 11-6Clostridium botulinum toxin test
- Track 11-7Clostridium tetani test
Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the applying heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on different diseases and their causes. Infections can be cured by various antimicrobials.
- Track 12-1Awareness of STD
- Track 12-2Medication
- Track 12-3Global health
- Track 12-4Vaccines
- Track 12-5Alternative therapies
- Track 12-6Detection of molecular targets for drug development
- Track 12-7Good hygienic practices
- Track 12-8Infection prevention
- Track 12-9Infection control
- Track 12-10Infectious diseases diagnosis
- Track 12-11Infectious diseases treatment and cure
- Track 12-12Public awareness about emerging infectious diseases
Vaccination is a process of administration of an antigenic material (vaccine) into a living mechanism. The clinical effect desired is to cause stimulation of an individual's immune system in order to develop an adaptive immunity against the pathogen constituting the vaccine. Vaccination is the most effective method of prevention for infectious diseases. Vaccine Adjuvants are components which potentiate the immune system and accelerate the immune responses to an antigen. These components act to induce, prolong, and enhance antigen-specific immune responses when used in combination with specific vaccine antigens.
Antimicrobial is the agent that kills or restricts the cell growth. To fight against the potential bacteria now-a-days, the manufacturing companies are coming up with more advanced antimicrobial liquids/soaps/sanitizers. Immunization/Vaccination is one of the most cost effective public health interventions to date, saving millions of lives and protecting countless children from illness and disability. As a direct result of immunization, polio is on the verge of eradication.
- Track 13-1Teixobactin
- Track 13-2Predatory bacteria
- Track 13-3Delivery of antibiotics to our body
- Track 13-4Bacterial Biofilms
- Track 13-5Antibiotics versus good bacteria in gut
Emerging infectious diseases are those which are caused by bacteria like E.coli, Salmonella, H.pylori, N.gonorrhoeae, N.meningitidis, S.aureus, and S.bacteria. It includes diseases like pneumonia, meningitis, gastroenteritis, urinary tract infections. Case Reports from vaccine manufactures and industrial microbiology supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. The consumables, equipment and technology markets in the industrial bacteriology and Microbiology industry comes around nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.
- Track 14-1Innovative vaccine manufacturing technologies using bioreactors
- Track 14-2Designing tools for Bacterial Infections and Market Analysis
- Track 14-3Involvement of Bioprocess during Vaccine production for Infectious Diseases
- Track 14-4Importance of Computational Biology for Target Drugs and Market Analysis
- Track 14-5Case reports from vaccine Manufacturers
- Track 14-6Review and debate on latest discoveries in Bacteriology